simvastatin has been researched along with Cardiac Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, K; McKillip, J; Powers, EM; Powers, JG | 1 |
| Cross, MJ; Sidaway, JE; Wilkinson, EL | 1 |
| Cheng, TP; Jian, YP; Li, HM; Li, Y; Liu, C; Liu, X; Ou, JS; Ou, ZJ; Quon, MJ; Shi, MM; Wang, ZP; Wang, ZQ; Xu, YQ; Xu, Z; Zhang, CX; Zhang, W; Zhang, X; Zhou, L | 1 |
| Demyanets, S; Hohensinner, PJ; Huber, K; Kaun, C; Krychtiuk, KA; Lenz, M; Pentz, R; Stojkovic, S; Thaler, B; Wojta, J; Zuckermann, A | 1 |
| Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL | 1 |
| Björnsson, E; Enders, F; Lindor, KD; Suwanwalaikorn, S; Treeprasertsuk, S | 1 |
| Campbell, SM; Godman, B; Gustafsson, LL; Pichetti, S; Sermet, C | 1 |
| Adabag, S; Ishani, A; Kuskowski, M; McFalls, E; Mithani, S; Slinin, Y | 1 |
| Bao, MC; Bu, PL; Chen, YG; Gao, HQ; Ji, XP; Li, CB; Li, XX; Zhang, J; Zhang, Y | 1 |
| Chen, DY; Huang, X | 1 |
| Faust, M | 1 |
| Susekov, AV | 1 |
| Ogrin, C; Perkelvald, A; Winer, N | 1 |
| Damkier, P; Hallas, J; Korsholm, L; Kristensen, SR; Mickley, H; Poulsen, TS; Vinholt, P | 1 |
| Bax, JJ; Davignon, J; Dunkelgrun, M; Feringa, HH; Hoeks, SE; Kastelein, JJ; Poldermans, D; Schouten, O; van Domburg, RT; Vidakovic, R; Welten, GM | 1 |
| Shepherd, J | 1 |
| Reynolds, TM; Wierzbicki, AS | 1 |
3 review(s) available for simvastatin and Cardiac Diseases
| Article | Year |
|---|---|
A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.
Topics: Animals; Azetidines; Drug Combinations; Drug Discovery; Ezetimibe, Simvastatin Drug Combination; Heart Diseases; Humans; Hyperlipidemias; Hypolipidemic Agents; Simvastatin | 2012 |
[Practical aspects of "Heart Protection Studies"].
Topics: Anticholesteremic Agents; Heart Diseases; Humans; Simvastatin; Treatment Outcome | 2004 |
Statin therapy in clinical practice: new developments.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Enzyme Inhibitors; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Middle Aged; Myocardial Infarction; Simvastatin | 1995 |
2 trial(s) available for simvastatin and Cardiac Diseases
| Article | Year |
|---|---|
Simvastatin Treatment Protects Myocardium in Noncoronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting.
Topics: Adult; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Cells, Cultured; China; Drug Administration Schedule; Elective Surgical Procedures; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; MicroRNAs; Middle Aged; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Signal Transduction; Simvastatin; Treatment Outcome | 2018 |
Heart protection study: a focus on diabetic patients.
Topics: Coronary Disease; Diabetic Angiopathies; Double-Blind Method; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Placebos; Simvastatin; Stroke | 2004 |
12 other study(ies) available for simvastatin and Cardiac Diseases
| Article | Year |
|---|---|
Effect of statin use on incidence of eczema and atopic dermatitis: A retrospective cohort study.
Topics: Adult; Age Factors; Atorvastatin; Dermatitis, Atopic; Dose-Response Relationship, Drug; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Simvastatin; Young Adult | 2021 |
Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cells.
Topics: Antibiotics, Antineoplastic; Capillary Permeability; Cardiotoxicity; Cells, Cultured; Coronary Vessels; Cytoprotection; Dose-Response Relationship, Drug; Doxorubicin; Endothelial Cells; Enzyme Activation; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitogen-Activated Protein Kinase 7; Protein Prenylation; Protein Transport; Quinolines; RNA Interference; Rosuvastatin Calcium; Signal Transduction; Simvastatin; Tight Junctions; Transfection; Zonula Occludens-1 Protein | 2018 |
Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissue.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cyclohexenes; Cytokines; Diphosphonates; Fibroblasts; Fluvastatin; Gene Expression Regulation; Heart; Heart Diseases; Humans; Interleukin-33; Lovastatin; Mevalonic Acid; Monoterpenes; Myocardium; Myocytes, Cardiac; Pravastatin; Pyridines; rhoA GTP-Binding Protein; Simvastatin; Thiazolidines | 2018 |
Clinical features related to statin-associated muscle symptoms.
Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People | 2019 |
NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Cause of Death; Chi-Square Distribution; Decision Support Techniques; Fatty Liver; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Liver Cirrhosis; Logistic Models; Male; Metformin; Middle Aged; Minnesota; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Odds Ratio; Predictive Value of Tests; Prognosis; Risk Factors; Severity of Illness Index; Simvastatin; Time Factors; Young Adult | 2013 |
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atorvastatin; Diabetes Mellitus; Drug Prescriptions; Drugs, Generic; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; France; General Practitioners; Heart Diseases; Heptanoic Acids; Humans; Indoles; Lipid Metabolism Disorders; Male; Middle Aged; Models, Statistical; Practice Patterns, Physicians'; Pravastatin; Prescription Drugs; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2013 |
Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Cohort Studies; Comorbidity; Coronary Artery Bypass; Coronary Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Postoperative Care; Postoperative Complications; Premedication; Renal Dialysis; Simvastatin; Survival Rate | 2011 |
Simvastatin exerts cardioprotective effects and inhibits the activity of Rho-associated protein kinase in rats with metabolic syndrome.
Topics: Animals; Cardiotonic Agents; Heart; Heart Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Metabolic Syndrome; Mitochondrial Swelling; Myocardium; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Phosphatase 1; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; Simvastatin; Vacuoles | 2012 |
[Statin treatment in type 2 diabetes. Is it a must today?].
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 2; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Insulin Resistance; Life Style; Middle Aged; Placebos; Pravastatin; Primary Prevention; Risk Factors; Simvastatin | 2003 |
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.
Topics: Aged; Atorvastatin; Blood Platelets; Cholesterol, LDL; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Simvastatin; Ticlopidine; Time Factors; Wound Healing | 2005 |
Effect of statin withdrawal on frequency of cardiac events after vascular surgery.
Topics: Aged; Atorvastatin; Electrocardiography; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pravastatin; Pyrroles; Simvastatin; Substance Withdrawal Syndrome; Troponin T; Vascular Surgical Procedures | 2007 |
Cholesterol: how low is low enough? Doctors have been slow in getting evidence on lowering cholesterol into practice.
Topics: Anticholesteremic Agents; Cholesterol; Evidence-Based Medicine; Heart Diseases; Humans; Simvastatin | 1999 |